Position in SVTR
Snapshot 2026-11-04- Startup SignalsRankedof 2,319↓71
- Life SciencesRankedof 244↓7
- Medtech DeviceRankedof 47↓3
About
Shanghai Sibo Huiyi Technology develops a fully automatic magnetically controlled interventional surgery robot platform for cerebrovascular procedures, driven by a vision-language-action (VLA) foundation model trained via self-reinforcement learning in a physics-simulation world model, with 4D-DSA digital-twin hardware.
Full tier & rationale — an SVTR Intelligence benefit
Capital graph
Company· 4
Funding history
- 2026-09-17Pre-Series A+近亿元
Investors · 诺庾资本, 浦东创投, 片仔癀盈科基金, 同杨基金, 太湖空天动力启明星Source · chinaventure.com.cn ↗
Comparable companies· by market
This company
BusinessLatest roundTotal raisedDate- 思博慧医
Fully autonomous magnetically guided neurointerventional surgical robot driven by a VLA large model
Series A · 2026-09
—
United States
BusinessLatest roundTotal raisedDate- Overture Life
Robotic IVF devices that automate handling and preparation of eggs and embryos
Undisclosed · $21M · 2025-04
$21M - ZAP Surgical Systems
ZAP-X gyroscopic self-shielded robotic radiosurgery system and ZAP-Axon treatment planning software for academic medical centers…
2026-10
— - Monteris Medical
Develops robotically controlled, MR-guided laser ablation systems for minimally invasive brain surgery
Series D+ · $178M · 2026-03
$178M
China
BusinessLatest roundTotal raisedDate- 睿心医疗
Developer of AI precision diagnosis and treatment platforms for cardiovascular and cerebrovascular disease and of vascular interventional surgical rob…
Strategic · 2026-07
— - 深度医疗
R&D and manufacturing of the FUNZAR microsurgery robot for hospital ophthalmology, orthopedics, neurosurgery, plastic surgery and other departments…
Series B · 2026-10
— - Abrobo
R&D, manufacturing, sales and leasing of pan-vascular interventional surgical robots (PANVIS® series)
Series A · 2026-10
—
Europe
BusinessLatest roundTotal raisedDate- Vitestro
Developed a device that integrates AI with ultrasound imaging and robotics to automate blood collection
Series B · $120M · 2026-03
$120M - Nami Surgical
Miniature ultrasonic medical devices for surgery; high-performance small ultrasonic scalpels designed to overcome obstacles in robot-assisted surgery
Undisclosed · $4M · 2024-05
$4M - Hypervision Surgical
Surgical intelligence venture incubated at King's College London; AI-driven hyperspectral imaging assesses tissue status in real time during surgery
Series A · $23M · 2026-05
$23M
Other / unspecified
BusinessLatest roundTotal raisedDate- IMeditech
R&D and manufacturing of electrospun nanofiber wound care devices, vascular stents, catheters and neurointerventional devices…
$1.1B
$1.1B - Scopia Surgical
AI surgical navigation software combining real-time spatial intelligence and patient-specific digital twins for robot-assisted and minimally invasive …
Pre-Seed · $3M · 2026-09
$3M - iPreg Inc.
Assisted reproduction devices: SperSort™ biomimetic antibody-free microfluidic sperm sorting chip and companion equipment for fertility centers; also …
—
Confirmed rounds only. Matched on subsector, sector, stage and funding scale — each verifiable on the company profiles.
Investors that may fit
Dimension Capital
10 Life Sciences deals in the last 24 months · 5 at a nearby stage · 1 in East China
Request intro →OrbiMed Advisors
9 Life Sciences deals in the last 24 months · 5 at a nearby stage · 4 in East China
Request intro →Qiming Venture Partners
9 Life Sciences deals in the last 24 months · 6 at a nearby stage · 7 in East China
Request intro →Lilly Asia Ventures
8 Life Sciences deals in the last 24 months · 6 at a nearby stage · 7 in East China
Request intro →HongShan
7 Life Sciences deals in the last 24 months · 3 at a nearby stage · 6 in East China
Request intro →Matrix Partners China
6 Life Sciences deals in the last 24 months · 6 at a nearby stage · 4 in East China
Request intro →Ranked by each firm’s deals in this sector over the last 24 months, weighted by nearby stage and shared geography. Indicative only — no rating judgment.